Clinically, inhibitors of the angiotensin II signaling pathway, such as AT1R blockers, are widely used in the treatment of hypertension, especially for patients with diabetes, heart failure, or stroke, and have few critical side effects [16, 17]. The gene discussed is AGTR1; the disease is hypertensive disorder.